O36.012
Maternal care for anti-D [Rh] antibodies, second trimester
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code O36.012 pertains to maternal care specifically focused on managing Anti-D (Rh) antibodies during the second trimester of pregnancy. This condition, known as Rh incompatibility, involves the mother's immune response to the Rh-positive red blood cells of her fetus. Proper management during pregnancy is essential to prevent complications such as hemolytic disease of the fetus and newborn. This guide provides an overview of what this condition entails, its causes, common symptoms, methods for diagnosis, and treatment options available to ensure the health of both mother and baby.
Causes & Symptoms
Clinical Causes: Rh incompatibility between mother and fetus, where the mother is Rh-negative and the fetus is Rh-positive. Previous pregnancy with an Rh-positive baby, leading to sensitization. Blood transfusions involving Rh-positive blood without adequate precautions. Certain obstetric procedures that may cause mixing of maternal and fetal blood.
Key Symptoms: Generally, there are no symptoms during pregnancy related to Rh incompatibility unless hemolytic disease develops in the fetus. In severe cases, signs of fetal anemia such as rapid heartbeat, swelling, or fluid build-up may be detected via ultrasound. In rare instances, the mother may experience symptoms if her immune system becomes highly activated, but this is uncommon solely because of Rh incompatibility.
Diagnostic & Treatment
Diagnosis Path: Diagnosis mainly involves blood tests for both mother and fetus:
Treatment Protocols: Management strategies aim to prevent or reduce the effects of Rh incompatibility:
Clinical Advice & FAQs
Billing Guidance
Is O36.012 a billable ICD-10 code?
Yes, O36.012 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report O36.012?
Clinical documentation must specify the nature of Maternal care for anti-D [Rh] antibodies, second trimester and any associated comorbidities for accurate reporting.
Cite this Clinical Reference